-
Je něco špatně v tomto záznamu ?
Actual body weight-based vancomycin dosing in neonates
P. Pokorná, M. Šíma, O. Černá, K. Allegaert, D. Tibboel, O. Slanař,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- antibakteriální látky aplikace a dávkování farmakokinetika MeSH
- lidé MeSH
- monitorování léčiv MeSH
- nomogramy MeSH
- novorozenec MeSH
- sepse farmakoterapie MeSH
- tělesná hmotnost MeSH
- vankomycin aplikace a dávkování farmakokinetika MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
This study aimed to explore vancomycin pharmacokinetics and its covariates in critically ill neonates and to propose an easy applicable dosing nomogram for initial treatment. Individual vancomycin pharmacokinetic parameters were calculated based on therapeutic drug monitoring data using a one-compartmental model. A linear regression model was used for examination of covariates. The mean (SD) volume of distribution (Vd) and clearance (CL) for vancomycin were 0.73 (0.31) L/kg and 0.052 (0.020) L/h/kg, respectively. Vd was related to actual body weight (ABW), gestational and postmenstrual age. CL was also associated with ABW, gestational, postmenstrual age and also creatinine clearance. ABW was the strongest predictor for vancomycin pharmacokinetics and consequently dosing. Loading dose (mg) of 11.81 × ABW (kg) + 7.86 and maintenance dose (mg/day) of 40.92 × ABW (kg) -22.18 most closely approximated pharmacokinetic target. Vancomycin pharmacokinetics was mainly influenced by ABW in neonates and a practical ABW-based dosing algorithm was developed.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023634
- 003
- CZ-PrNML
- 005
- 20201214130652.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/1120009X.2019.1599574 $2 doi
- 035 __
- $a (PubMed)30983533
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Pokorná, Pavla $u Department of Pediatrics - PICU/NICU, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Prague , Czech Republic. Department of Pharmacology, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Czech Republic , Prague , Czech Republic. Intensive Care and Department of Pediatric Surgery, Erasmus MC and Department of Neonatology- Sophia Childrens Hospital , Rotterdam , The Netherlands.
- 245 10
- $a Actual body weight-based vancomycin dosing in neonates / $c P. Pokorná, M. Šíma, O. Černá, K. Allegaert, D. Tibboel, O. Slanař,
- 520 9_
- $a This study aimed to explore vancomycin pharmacokinetics and its covariates in critically ill neonates and to propose an easy applicable dosing nomogram for initial treatment. Individual vancomycin pharmacokinetic parameters were calculated based on therapeutic drug monitoring data using a one-compartmental model. A linear regression model was used for examination of covariates. The mean (SD) volume of distribution (Vd) and clearance (CL) for vancomycin were 0.73 (0.31) L/kg and 0.052 (0.020) L/h/kg, respectively. Vd was related to actual body weight (ABW), gestational and postmenstrual age. CL was also associated with ABW, gestational, postmenstrual age and also creatinine clearance. ABW was the strongest predictor for vancomycin pharmacokinetics and consequently dosing. Loading dose (mg) of 11.81 × ABW (kg) + 7.86 and maintenance dose (mg/day) of 40.92 × ABW (kg) -22.18 most closely approximated pharmacokinetic target. Vancomycin pharmacokinetics was mainly influenced by ABW in neonates and a practical ABW-based dosing algorithm was developed.
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $7 D000900
- 650 _2
- $a tělesná hmotnost $7 D001835
- 650 _2
- $a monitorování léčiv $7 D016903
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nomogramy $7 D049451
- 650 _2
- $a sepse $x farmakoterapie $7 D018805
- 650 _2
- $a vankomycin $x aplikace a dávkování $x farmakokinetika $7 D014640
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Šíma, Martin $u Department of Pharmacology, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Czech Republic , Prague , Czech Republic.
- 700 1_
- $a Černá, Olga $u Department of Pediatrics - PICU/NICU, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Prague , Czech Republic.
- 700 1_
- $a Allegaert, Karel $u Intensive Care and Department of Pediatric Surgery, Erasmus MC and Department of Neonatology- Sophia Childrens Hospital , Rotterdam , The Netherlands. Department of development and regeneration , Katholieke Universiteit Leuven , Leuven , Belgium.
- 700 1_
- $a Tibboel, Dick $u Department of Pediatrics - PICU/NICU, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Prague , Czech Republic. Intensive Care and Department of Pediatric Surgery, Erasmus MC and Department of Neonatology- Sophia Childrens Hospital , Rotterdam , The Netherlands.
- 700 1_
- $a Slanař, Ondřej $u Department of Pharmacology, General University Hospital, 1st Faculty of Medicine Charles University in Prague , Czech Republic , Prague , Czech Republic.
- 773 0_
- $w MED00181505 $t Journal of chemotherapy (Florence, Italy) $x 1973-9478 $g Roč. 31, č. 6 (2019), s. 307-312
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30983533 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130651 $b ABA008
- 999 __
- $a ok $b bmc $g 1595953 $s 1114310
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 31 $c 6 $d 307-312 $e 20190414 $i 1973-9478 $m Journal of chemotherapy $n J Chemother $x MED00181505
- LZP __
- $a Pubmed-20201125
